>AT1G19050.1 | ARR7 (RESPONSE REGULATOR 7) transcription regulator/ two-component response regulator
MAVGEVMRMEIPAGGDLTVTTPELHVLAVDDSIVDRKVIERLLRISSCKVTTVESGTRAL
QYLGLDGGKGASNLKDLKVNLIVTDYSMPGLSGYDLLKKIKESSAFREVPVVIMSSENIL
PRIQECLKEGAEEFLLKPVKLADVKRIKQLIMRNEAEECKILSHSNKRKLQEDSDTSSSS
HDDTSIKDSSCSKRMKSESENLFSLL*
>AT5G42020.1 | BIP2 ATP binding
MARSFGANSTVVLAIIFFGCLFAFSTAKEEATKLGSVIGIDLGTTYSCVGVYKNGHVEII
ANDQGNRITPSWVGFTDSERLIGEAAKNQAAVNPERTVFDVKRLIGRKFEDKEVQKDRKL
VPYQIVNKDGKPYIQVKIKDGETKVFSPEEISAMILTKMKETAEAYLGKKIKDAVVTVPA
YFNDAQRQATKDAGVIAGLNVARIINEPTAAAIAYGLDKKGGEKNILVFDLGGGTFDVSV
LTIDNGVFEVLSTNGDTHLGGEDFDHRIMEYFIKLIKKKHQKDISKDNKALGKLRRECER
AKRALSSQHQVRVEIESLFDGVDLSEPLTRARFEELNNDLFRKTMGPVKKAMDDAGLQKS
QIDEIVLVGGSTRIPKVQQLLKDFFEGKEPNKGVNPDEAVAYGAAVQGGILSGEGGDETK
DILLLDVAPLTLGIETVGGVMTKLIPRNTVIPTKKSQVFTTYQDQQTTVSIQVFEGERSL
TKDCRLLGKFDLTGVPPAPRGTPQIEVTFEVDANGILNVKAEDKASGKSEKITITNEKGR
LSQEEIDRMVKEAEEFAEEDKKVKEKIDARNALETYVYNMKNQVSDKDKLADKLEGDEKE
KIEAATKEALEWLDENQNSEKEEYDEKLKEVEAVCNPIITAVYQRSGGAPGAGGESSTEE
EDESHDEL*
>AT5G42020.1 | BIP2 ATP binding
MARSFGANSTVVLAIIFFGCLFAFSTAKEEATKLGSVIGIDLGTTYSCVGVYKNGHVEII
ANDQGNRITPSWVGFTDSERLIGEAAKNQAAVNPERTVFDVKRLIGRKFEDKEVQKDRKL
VPYQIVNKDGKPYIQVKIKDGETKVFSPEEISAMILTKMKETAEAYLGKKIKDAVVTVPA
YFNDAQRQATKDAGVIAGLNVARIINEPTAAAIAYGLDKKGGEKNILVFDLGGGTFDVSV
LTIDNGVFEVLSTNGDTHLGGEDFDHRIMEYFIKLIKKKHQKDISKDNKALGKLRRECER
AKRALSSQHQVRVEIESLFDGVDLSEPLTRARFEELNNDLFRKTMGPVKKAMDDAGLQKS
QIDEIVLVGGSTRIPKVQQLLKDFFEGKEPNKGVNPDEAVAYGAAVQGGILSGEGGDETK
DILLLDVAPLTLGIETVGGVMTKLIPRNTVIPTKKSQVFTTYQDQQTTVSIQVFEGERSL
TKDCRLLGKFDLTGVPPAPRGTPQIEVTFEVDANGILNVKAEDKASGKSEKITITNEKGR
LSQEEIDRMVKEAEEFAEEDKKVKEKIDARNALETYVYNMKNQVSDKDKLADKLEGDEKE
KIEAATKEALEWLDENQNSEKEEYDEKLKEVEAVCNPIITAVYQRSGGAPGAGGESSTEE
EDESHDEL*
>AT5G42020.2 | BIP2 ATP binding
MARSFGANSTVVLAIIFFGCLFAFSTAKEEATKLGSVIGIDLGTTYSCVGVYKNGHVEII
ANDQGNRITPSWVGFTDSERLIGEAAKNQAAVNPERTVFDVKRLIGRKFEDKEVQKDRKL
VPYQIVNKDGKPYIQVKIKDGETKVFSPEEISAMILTKMKETAEAYLGKKIKDAVVTVPA
YFNDAQRQATKDAGVIAGLNVARIINEPTAAAIAYGLDKKGGEKNILVFDLGGGTFDVSV
LTIDNGVFEVLSTNGDTHLGGEDFDHRIMEYFIKLIKKKHQKDISKDNKALGKLRRECER
AKRALSSQHQVRVEIESLFDGVDLSEPLTRARFEELNNDLFRKTMGPVKKAMDDAGLQKS
QIDEIVLVGGSTRIPKVQQLLKDFFEGKEPNKGVNPDEAVAYGAAVQGGILSGEGGDETK
DILLLDVAPLTLGIETVGGVMTKLIPRNTVIPTKKSQVFTTYQDQQTTVSIQVFEGERSL
TKDCRLLGKFDLTGVPPAPRGTPQIEVTFEKIDARNALETYVYNMKNQVSDKDKLADKLE
GDEKEKIEAATKEALEWLDENQNSEKEEYDEKLKEVEAVCNPIITAVYQRSGGAPGAGGE
SSTEEEDESHDEL*
>AT5G42020.2 | BIP2 ATP binding
MARSFGANSTVVLAIIFFGCLFAFSTAKEEATKLGSVIGIDLGTTYSCVGVYKNGHVEII
ANDQGNRITPSWVGFTDSERLIGEAAKNQAAVNPERTVFDVKRLIGRKFEDKEVQKDRKL
VPYQIVNKDGKPYIQVKIKDGETKVFSPEEISAMILTKMKETAEAYLGKKIKDAVVTVPA
YFNDAQRQATKDAGVIAGLNVARIINEPTAAAIAYGLDKKGGEKNILVFDLGGGTFDVSV
LTIDNGVFEVLSTNGDTHLGGEDFDHRIMEYFIKLIKKKHQKDISKDNKALGKLRRECER
AKRALSSQHQVRVEIESLFDGVDLSEPLTRARFEELNNDLFRKTMGPVKKAMDDAGLQKS
QIDEIVLVGGSTRIPKVQQLLKDFFEGKEPNKGVNPDEAVAYGAAVQGGILSGEGGDETK
DILLLDVAPLTLGIETVGGVMTKLIPRNTVIPTKKSQVFTTYQDQQTTVSIQVFEGERSL
TKDCRLLGKFDLTGVPPAPRGTPQIEVTFEKIDARNALETYVYNMKNQVSDKDKLADKLE
GDEKEKIEAATKEALEWLDENQNSEKEEYDEKLKEVEAVCNPIITAVYQRSGGAPGAGGE
SSTEEEDESHDEL*
>AT5G62390.1 | ATBAG7 (ARABIDOPSIS THALIANA BCL-2-ASSOCIATED ATHANOGENE 7) calmodulin binding
MTLFHRLDLIDPYTCTPLIVRETSIVEPSSLFLGFPSFIDEDIEDLFEFSSPNPLDLFET
VTDLVKIKKSPSSCKYKVIRRRLEPEYPLKYLCDRVSDLESKFDRLVSPKSDRKYTLTKE
IKGSGERKYKWEAEIQGPLERKYKLEAEIEGSGERKYRWTTEIKGGKKDEEGLKLAALKK
EKAKAKAIAAAEAEKKKNKNKKKSYNWTTEVKSERENGEVSHTYIIKATTGGEKKKKHEE
KEKKEKIETKSKKKEKTRVVVIEEEEEEDDESSEHGAIVLRKAFSRRNGAVRTKKGKNKE
MPPEYAAVMIQRAFKAYLIRRSKSLRALRDLAIAKTKLKELRASFHNFSYRRLIARDGEE
RQKFSEKIIVLLLTVDAIEGVDVMVRGAKRSMVDELEAMLDVVDPQPQGKSLSMRRRTFD
MPDSLIRKEIAEGVTQIVQMLETEEE*
>AT5G02500.1 | HSC70-1 (HEAT SHOCK COGNATE PROTEIN 70-1) ATP binding
MSGKGEGPAIGIDLGTTYSCVGVWQHDRVEIIANDQGNRTTPSYVAFTDSERLIGDAAKN
QVAMNPVNTVFDAKRLIGRRFSDSSVQSDMKLWPFKIQAGPADKPMIYVEYKGEEKEFAA
EEISSMVLIKMREIAEAYLGVTIKNAVVTVPAYFNDSQRQATKDAGVIAGLNVMRIINEP
TAAAIAYGLDKKATSVGEKNVLIFDLGGGTFDVSLLTIEEGIFEVKATAGDTHLGGEDFD
NRMVNHFVQEFKRKSKKDITGNPRALRRLRTSCERAKRTLSSTAQTTIEIDSLYEGIDFY
STITRARFEELNMDLFRKCMEPVEKCLRDAKMDKSTVHDVVLVGGSTRIPKVQQLLQDFF
NGKELCKSINPDEAVAYGAAVQGAILSGEGNEKVQDLLLLDVTPLSLGLETAGGVMTTLI
PRNTTIPTKKEQVFSTYSDNQPGVLIQVYEGERARTKDNNLLGKFELSGIPPAPRGVPQI
TVCFDIDANGILNVSAEDKTTGQKNKITITNDKGRLSKDEIEKMVQEAEKYKSEDEEHKK
KVEAKNALENYAYNMRNTIQDEKIGEKLPAADKKKIEDSIEQAIQWLEGNQLAEADEFED
KMKELESICNPIIAKMYQGAGGEAGGPGASGMDDDAPPASGGAGPKIEEVD*
>AT5G02500.1 | HSC70-1 (HEAT SHOCK COGNATE PROTEIN 70-1) ATP binding
MSGKGEGPAIGIDLGTTYSCVGVWQHDRVEIIANDQGNRTTPSYVAFTDSERLIGDAAKN
QVAMNPVNTVFDAKRLIGRRFSDSSVQSDMKLWPFKIQAGPADKPMIYVEYKGEEKEFAA
EEISSMVLIKMREIAEAYLGVTIKNAVVTVPAYFNDSQRQATKDAGVIAGLNVMRIINEP
TAAAIAYGLDKKATSVGEKNVLIFDLGGGTFDVSLLTIEEGIFEVKATAGDTHLGGEDFD
NRMVNHFVQEFKRKSKKDITGNPRALRRLRTSCERAKRTLSSTAQTTIEIDSLYEGIDFY
STITRARFEELNMDLFRKCMEPVEKCLRDAKMDKSTVHDVVLVGGSTRIPKVQQLLQDFF
NGKELCKSINPDEAVAYGAAVQGAILSGEGNEKVQDLLLLDVTPLSLGLETAGGVMTTLI
PRNTTIPTKKEQVFSTYSDNQPGVLIQVYEGERARTKDNNLLGKFELSGIPPAPRGVPQI
TVCFDIDANGILNVSAEDKTTGQKNKITITNDKGRLSKDEIEKMVQEAEKYKSEDEEHKK
KVEAKNALENYAYNMRNTIQDEKIGEKLPAADKKKIEDSIEQAIQWLEGNQLAEADEFED
KMKELESICNPIIAKMYQGAGGEAGGPGASGMDDDAPPASGGAGPKIEEVD*
>AT5G02500.2 | HSC70-1 (HEAT SHOCK COGNATE PROTEIN 70-1) ATP binding
MSGKGEGPAIGIDLGTTYSCVGVWQHDRVEIIANDQGNRTTPSYVAFTDSERLIGDAAKN
QVAMNPVNTVFDAKRLIGRRFSDSSVQSDMKLWPFKIQAGPADKPMIYVEYKGEEKEFAA
EEISSMVLIKMREIAEAYLGVTIKNAVVTVPAYFNDSQRQATKDAGVIAGLNVMRIINEP
TAAAIAYGLDKKATSVGEKNVLIFDLGGGTFDVSLLTIEEGIFEVKATAGDTHLGGEDFD
NRMVNHFVQEFKRKSKKDITGNPRALRRLRTSCERAKRTLSSTAQTTIEIDSLYEGIDFY
STITRARFEELNMDLFRKCMEPVEKCLRDAKMDKSTVHDVVLVGGSTRIPKVQQLLQDFF
NGKELCKSINPDEAVAYGAAVQGAILSGEGNEKMVQEAEKYKSEDEEHKKKVEAKNALEN
YAYNMRNTIQDEKIGEKLPAADKKKIEDSIEQAIQWLEGNQLAEADEFEDKMKELESICN
PIIAKMYQGAGGEAGGPGASGMDDDAPPASGGAGPKIEEVD*
>AT5G02500.2 | HSC70-1 (HEAT SHOCK COGNATE PROTEIN 70-1) ATP binding
MSGKGEGPAIGIDLGTTYSCVGVWQHDRVEIIANDQGNRTTPSYVAFTDSERLIGDAAKN
QVAMNPVNTVFDAKRLIGRRFSDSSVQSDMKLWPFKIQAGPADKPMIYVEYKGEEKEFAA
EEISSMVLIKMREIAEAYLGVTIKNAVVTVPAYFNDSQRQATKDAGVIAGLNVMRIINEP
TAAAIAYGLDKKATSVGEKNVLIFDLGGGTFDVSLLTIEEGIFEVKATAGDTHLGGEDFD
NRMVNHFVQEFKRKSKKDITGNPRALRRLRTSCERAKRTLSSTAQTTIEIDSLYEGIDFY
STITRARFEELNMDLFRKCMEPVEKCLRDAKMDKSTVHDVVLVGGSTRIPKVQQLLQDFF
NGKELCKSINPDEAVAYGAAVQGAILSGEGNEKMVQEAEKYKSEDEEHKKKVEAKNALEN
YAYNMRNTIQDEKIGEKLPAADKKKIEDSIEQAIQWLEGNQLAEADEFEDKMKELESICN
PIIAKMYQGAGGEAGGPGASGMDDDAPPASGGAGPKIEEVD*
>AT5G28540.1 | BIP1 ATP binding
MARSFGANSTVVLAIIFFGCLFALSSAIEEATKLGSVIGIDLGTTYSCVGVYKNGHVEII
ANDQGNRITPSWVGFTDSERLIGEAAKNQAAVNPERTVFDVKRLIGRKFEDKEVQKDRKL
VPYQIVNKDGKPYIQVKIKDGETKVFSPEEISAMILTKMKETAEAYLGKKIKDAVVTVPA
YFNDAQRQATKDAGVIAGLNVARIINEPTAAAIAYGLDKKGGEKNILVFDLGGGTFDVSV
LTIDNGVFEVLSTNGDTHLGGEDFDHRVMEYFIKLIKKKHQKDISKDNKALGKLRRECER
AKRALSSQHQVRVEIESLFDGVDFSEPLTRARFEELNNDLFRKTMGPVKKAMDDAGLQKS
QIDEIVLVGGSTRIPKVQQLLKDFFEGKEPNKGVNPDEAVAYGAAVQGGILSGEGGDETK
DILLLDVAPLTLGIETVGGVMTKLIPRNTVIPTKKSQVFTTYQDQQTTVSIQVFEGERSL
TKDCRLLGKFDLNGIPPAPRGTPQIEVTFEVDANGILNVKAEDKASGKSEKITITNEKGR
LSQEEIDRMVKEAEEFAEEDKKVKEKIDARNALETYVYNMKNQVNDKDKLADKLEGDEKE
KIEAATKEALEWLDENQNSEKEEYDEKLKEVEAVCNPIITAVYQRSGGAPGGAGGESSTE
EEDESHDEL*
>AT5G45420.1 | myb family transcription factor
MDFFDEDRPRFVFQSRPSSSHTAEEEEEARIPNKLFISISVSISLIILSLSFFYFESEPA
KSLLLWLSLSFLVGPFAPSSLTGGKIRVGYGQILEPEQIHDESSTDNERESRRKSVNKRS
KGSTKSDNPPENASAVTEVSRKVVIPQSKESGSVNETKDWTAEEIEILKKQLIKHPAGKP
GRWETVASAFGGRYKTENVIKKAKEIGEKKIYESDDYAQFLKNRKASDPRLVDENEENSG
AGGDAEGTKEIWSNGEDIALLNALKAFPKEAAMRWEKIAAAVPGKSKAACMKRVTELKKG
FRSSKTPAN*
>AT5G10290.1 | leucine-rich repeat family protein / protein kinase family protein
MRMFSLQKMAMAFTLLFFACLCSFVSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCT
WSQVICDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSL
TSLDLEDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSG
QIPQSLFEIPKYNFTSNNLNCGGRQPHPCVSAVAHSGDSSKPKTGIIAGVVAGVTVVLFG
ILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGG
FGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTER
LLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKA
ANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYG
IMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMI
QVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRHEFERLQRRFDWGEDS
MHNQDAIELSGGR*
>AT5G24360.1 | IRE1-1 (INOSITOL REQUIRING 1-1) ATP binding / endoribonuclease producing 5-phosphomonoesters / kinase/ protein kinase/ protein serine/threonine kinase
MRGSALLDLILFLLVSPLAHSFKGSEISKFYDKSISNQISQSDRESGYVLVSTVDGSISL
VDMSSQKLDWTFHTNEPIYSSYQAPHYHYTTDEERSSVLGDDFYMDCDKDWRLYNSSVRK
GKRVNEIVDASEFIGTLPYTSTDRIVLGKKDTSVFLLDWKTGKLVKRYRMDELYSNTVVE
NDKEKAIVLSKEAPLLFGSGFKKSEDFPELVYIERKDFKIQCISKFGDVLWSVSYAKMEA
KLQNHESVQFISGLSSSVGKNQFPLSYTTSVPMVQLRNVKYETLFPRLGFLDEALYLPFQ
DRKPNQLAIGDGNQLTLPGNKEAEEVLSLPLPETVISQITDIIDGSTKQAGFASKFSGLI
VLIFGFCVTMLSVCGLFFYRLRQSIRIKEPYVSEVPIATPKKKKSKKNGTTKAVHKKENG
FISGGNKDPSHEENEKRLLTAFPGLNNSSAEGYRVGKLFVSNKEIAKGSNGTVVLEGSYE
GRLVAVKRLVQSHHDVAQKEILNLMASDKHSNIVRWYGVDQDEHFIYISLELCACSLNDL
IYASSALLESPMASSSIHSIQINPIFENGKGVELWKENGHPSPVLLKLMRDIVAGLVHLH
DIGIVHRDLKPQNVLIVKNSSLCAKLSDMGISKRLPADTSALTRNSTGLGSGSSGWQAPE
QLRNERQTRAVDLFSLGCVLFFCMTGGKHPYGDNYERDVNVLNDQKDLFLIESLPEAVHL
LTGLLNPDPNLRPRAQDVMHHPLFWNSDMRLSFLRDASDRVELENREEGSQLLAALESTA
AVTLNGRWDEKLDSIFLDNIGRYRRYKFDSIRDLLRVIRNKLNHYRELPKELQELLGSVP
EGFERYFSSRFPKLLIQVYTVLFDYCNNEEFFFKYSKTTVF*
>AT3G19840.1 | FF domain-containing protein / WW domain-containing protein
MLANAPFGRPGTLAPPGLMTSPPAFPGSNPFSTTPRPGMSAGPAQMNPGIHPHMYPPYHS
LPGTPQGMWLQPPSMGGIPRAPFLSHPTTFPGSYPFPVRGISPNLPYSGSHPLGASPMGS
VGNVHALPGRQPDISPGRKTEELSGIAGSQLVGNRLDAWTAHKSEAGVLYYYNSVTGQST
YEKPPGFGGEPDKVPVQPIPVSILPGTDWALVSTNDGKKYYYNNKTKVSSWQIPAEVKDF
GKKLEERAMESVASVPSADLTEKGSDLTSLSAPAISNGGRDAASLKTTNFGSSALDLVKK
KLHDSGMPVSSTITSEANSGKTTEVTPSGESGNSTGKVKDAPGAGALSDSSSDSEDEDSG
PSKEECSKQFKEMLKERGIAPFSKWEKELPKIIFDPRFKAIPSHSVRRSLFEQYVKTRAE
EERREKRAAHKAAIEGFRQLLDDASTDIDQHTDYRAFKKKWGNDLRFEAIERKEREGLLN
ERVLSLKRSAEQKAQEIRAAAASDFKTMLREREISINSHWSKVKDSLRNEPRYRSVAHED
REVFYYEYIAELKAAQRGDDHEMKARDEEDKLRERERELRKRKEREVQEVERVRQKIRRK
EASSSYQALLVEKIRDPEASWTESKPILERDPQKRASNPDLEPADKEKLFRDHVKSLYER
CVHDFKALLAEALSSEAATLQTEDGKTALNSWSTAKQVLKPDIRYSKMPRQDREVVWRRY
VEDISRKQRHENYQEEKQRDYKT*
>AT1G26560.1 | BGLU40 (BETA GLUCOSIDASE 40) catalytic/ cation binding / hydrolase hydrolyzing O-glycosyl compounds
MAHRRLIMTMTKMMMMVTMMMMMDKTCICADISRGSFPKGFVFGTASSAFQHEGAVKAEG
RGPTIWDTFSHTFGKITDFSNADVAVDQYHRYEEDVQLMKNMGMDAYRFSISWTRIFPNG
VGHINEAGIDHYNKLINALLAKGIEPYVTLYHWDLPQALHDRYLGWLNPQIINDFAAYAE
VCFQRFGDRVKHWITFNEPHTFAIQGYDVGLQAPGRCTILFKLTCREGNSSTEPYIVGHN
VILTHATVSDIYRKKYKAKQGGSLGIAFDVMWFEPESNKTEDIEAAQRAQDFQLGWFLDP
LMFGDYPSSMRSRVGSRLPVFTGSQSSLVKGSLDFVGINHYTTYYARNNATNLIGTLLHD
AVSDSGTVTLPFKGLSTIGDRASSIWLYIVPRGMRSLMNYIKHRYGNPPVFITENGMDDP
NSILISRKDALKDAKRIKYHHDYLSSLQASIKEDGCNVKGYFVWSLLDNWEWAAGYSSRF
GLYFVDYRDNLKRYPKDSVHWFTSFLNSTS*
>AT5G49910.1 | CPHSC70-2EAT SHOCK PROTEIN 70-2 (CHLOROPLAST HEAT SHOCK PROTEIN 70-2) ATP binding / unfolded protein binding
MASSAAQIHILGGIGFPTSSSSSSTKNLDNKTNSIPRSVFFGNRTSPFTTPTSAFLRMGR
RNNNASRYTVGPVRVVNEKVVGIDLGTTNSAVAAMEGGKPTIVTNAEGQRTTPSVVAYTK
SKDRLVGQIAKRQAVVNPENTFFSVKRFIGRRMNEVAEESKQVSYRVIKDENGNVKLDCP
AIGKQFAAEEISAQVLRKLVDDASRFLNDKVTKAVITVPAYFNDSQRTATKDAGRIAGLE
VLRIINEPTAASLAYGFERKSNETILVFDLGGGTFDVSVLEVGDGVFEVLSTSGDTHLGG
DDFDKRVVDWLASTFKKDEGIDLLKDKQALQRLTEAAEKAKIELSSLTQTNMSLPFITAT
ADGPKHIETTLTRGKFEELCSDLLDRVRTPVENSLRDAKLSFKDIDEVILVGGSTRIPAV
QDLVRKLTGKEPNVSVNPDEVVALGAAVQAGVLSGDVSDIVLLDVTPLSLGLETLGGVMT
KIIPRNTTLPTSKSEVFSTAADGQTSVEINVLQGEREFVRDNKSIGSFRLDGIPPAPRGV
PQIEVKFDIDANGILSVSASDKGTGKKQDITITGASTLPKDEVDTMVQEAERFAKEDKEK
RDAIDTKNQADSVVYQTEKQLKELGEKIPGPVKEKVEAKLQELKEKIASGSTQEIKDTMA
ALNQEVMQIGQSLYNQPQPGGADSPPGGEASSSSDTSSSAKGGDNGGDVIDADFTDSN*
>AT1G56410.1 | ERD2 (EARLY-RESPONSIVE TO DEHYDRATION 2) ATP binding
MAGKGEGPAIGIDLGTTYSCVGVWQHDRVEIIANDQGNRTTPSYVAFTDSERLIGDAAKN
QVAMNPVNTVFDAKRLIGRRFSDASVQSDMKFWPFKVTPGQADKPMIFVNYKGEEKQFAA
EEISSMVLIKMREIAEAYLGSSIKNAVVTVPAYFNDSQRQATKDAGVIAGLNVLRIINEP
TAAAIAYGLDKKATSVGIKNVLIFDLGGGTFDVSLLTIEEGIFEVKATAGDTHLGGEDFD
NRMVNHFVQEFKRKNKKDISGDARALRRLRTACERAKRTLSSTAQTTVEVDSLFEGIDFY
SPITRAKFEEMNMDLFRKCMEPVMKCLRDSKMDKSMVHDVVLVGGSTRIPKVQQLLQDFF
NGKELCKSINPDEAVAYGAAVQAAILSGEGNEKVQDLLLLDVTPLSLGIETIGGVMTTLI
QRNTTIPAKKEQEFTTTVDNQPDVLIQVYEGERARTIDNNILGQFVLSGIPPAPRGIPQF
TVCFDIDSNGILNVSAEDKATGKKNKITITNDKGRLSKDDIEKMVQEAEKYKSEDEEHKK
KVEAKNGLENYAYNVGNTLRDMGEKLPAADKKKFEDSIEEVIQWLDDNQLAEADEFEHKM
KELESVWSTIITKMYQG*
>AT1G05200.1 | ATGLR34 intracellular ligand-gated ion channel
MGFLVMIREVSMAKAIRVVLLCVSVLWVVPKECACRSNFSRNSSSSSSSSLRPLRQRPSS
VNVGALFTYDSFIGRAAKPAVKAAMDDVNADQSVLKGIKLNIIFQDSNCSGFIGTMGALQ
LMENKVVAAIGPQSSGIAHMISYVANELHVPLLSFGATDPTLSSLQFPYFLRTTQNDYFQ
MHAIADFLSYSGWRQVIAIFVDDECGRNGISVLGDVLAKKRSRISYKAAITPGADSSSIR
DLLVSVNLMESRVFVVHVNPDSGLNVFSVAKSLGMMASGYVWIATDWLPTAMDSMEHVDS
DTMDLLQGVVAFRHYTIESSVKRQFMARWKNLRPNDGFNSYAMYAYDSVWLVARALDVFF
RENNNITFSNDPNLHKTNGSTIQLSALSVFNEGEKFMKIILGMNHTGVTGPIQFDSDRNR
VNPAYEVLNLEGTAPRTVGYWSNHSGLSVVHPETLYSRPPNTSTANQRLKGIIYPGEVTK
PPRGWVFPNNGKPLRIGVPNRVSYTDYVSKDKNPPGVRGYCIDVFEAAIELLPYPVPRTY
ILYGDGKRNPSYDNLVNEVVADNFDVAVGDITIVTNRTRYVDFTQPFIESGLVVVAPVKE
AKSSPWSFLKPFTIEMWAVTGGFFLFVGAMVWILEHRFNQEFRGPPRRQLITIFWFSFST
MFFSHRENTVSSLGRFVLIIWLFVVLIINSSYTASLTSILTIRQLTSRIEGIDSLVTSNE
PIGVQDGTFARNYLINELNILPSRIVPLKDEEQYLSALQRGPNAGGVAAIVDELPYIEVL
LTNSNCKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLSEEGELEKIHRKWLNYKHE
CSMQISNSEDSQLSLKSFWGLFLICGITCFMALTVFFWRVFWQYQRLLPESADEERAGEV
SEPSRSGRGSRAPSFKELIKVVDKREAEIKEILKQKSSKKLKSTQSAAGTSQSQHGEIT*
>AT1G05200.1 | ATGLR34 intracellular ligand-gated ion channel
MGFLVMIREVSMAKAIRVVLLCVSVLWVVPKECACRSNFSRNSSSSSSSSLRPLRQRPSS
VNVGALFTYDSFIGRAAKPAVKAAMDDVNADQSVLKGIKLNIIFQDSNCSGFIGTMGALQ
LMENKVVAAIGPQSSGIAHMISYVANELHVPLLSFGATDPTLSSLQFPYFLRTTQNDYFQ
MHAIADFLSYSGWRQVIAIFVDDECGRNGISVLGDVLAKKRSRISYKAAITPGADSSSIR
DLLVSVNLMESRVFVVHVNPDSGLNVFSVAKSLGMMASGYVWIATDWLPTAMDSMEHVDS
DTMDLLQGVVAFRHYTIESSVKRQFMARWKNLRPNDGFNSYAMYAYDSVWLVARALDVFF
RENNNITFSNDPNLHKTNGSTIQLSALSVFNEGEKFMKIILGMNHTGVTGPIQFDSDRNR
VNPAYEVLNLEGTAPRTVGYWSNHSGLSVVHPETLYSRPPNTSTANQRLKGIIYPGEVTK
PPRGWVFPNNGKPLRIGVPNRVSYTDYVSKDKNPPGVRGYCIDVFEAAIELLPYPVPRTY
ILYGDGKRNPSYDNLVNEVVADNFDVAVGDITIVTNRTRYVDFTQPFIESGLVVVAPVKE
AKSSPWSFLKPFTIEMWAVTGGFFLFVGAMVWILEHRFNQEFRGPPRRQLITIFWFSFST
MFFSHRENTVSSLGRFVLIIWLFVVLIINSSYTASLTSILTIRQLTSRIEGIDSLVTSNE
PIGVQDGTFARNYLINELNILPSRIVPLKDEEQYLSALQRGPNAGGVAAIVDELPYIEVL
LTNSNCKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLSEEGELEKIHRKWLNYKHE
CSMQISNSEDSQLSLKSFWGLFLICGITCFMALTVFFWRVFWQYQRLLPESADEERAGEV
SEPSRSGRGSRAPSFKELIKVVDKREAEIKEILKQKSSKKLKSTQSAAGTSQSQHGEIT*
>AT1G05200.2 | ATGLR34 intracellular ligand-gated ion channel
MGFLVMIREVSMAKAIRVVLLCVSVLWVVPKECACRSNFSRNSSSSSSSSLRPLRQRPSS
VNVGALFTYDSFIGRAAKPAVKAAMDDVNADQSVLKGIKLNIIFQDSNCSGFIGTMGALQ
LMENKVVAAIGPQSSGIAHMISYVANELHVPLLSFGATDPTLSSLQFPYFLRTTQNDYFQ
MHAIADFLSYSGWRQVIAIFVDDECGRNGISVLGDVLAKKRSRISYKAAITPGADSSSIR
DLLVSVNLMESRVFVVHVNPDSGLNVFSVAKSLGMMASGYVWIATDWLPTAMDSMEHVDS
DTMDLLQGVVAFRHYTIESSVKRQFMARWKNLRPNDGFNSYAMYAYDSVWLVARALDVFF
RENNNITFSNDPNLHKTNGSTIQLSALSVFNEGEKFMKIILGMNHTGVTGPIQFDSDRNR
VNPAYEVLNLEGTAPRTVGYWSNHSGLSVVHPETLYSRPPNTSTANQRLKGIIYPGEVTK
PPRGWVFPNNGKPLRIGVPNRVSYTDYVSKDKNPPGVRGYCIDVFEAAIELLPYPVPRTY
ILYGDGKRNPSYDNLVNEVVADNFDVAVGDITIVTNRTRYVDFTQPFIESGLVVVAPVKE
AKSSPWSFLKPFTIEMWAVTGGFFLFVGAMVWILEHRFNQEFRGPPRRQLITIFWFSFST
MFFSHRENTVSSLGRFVLIIWLFVVLIINSSYTASLTSILTIRQLTSRIEGIDSLVTSNE
PIGVQDGTFARNYLINELNILPSRIVPLKDEEQYLSALQRGPNAGGVAAIVDELPYIEVL
LTNSNCKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLSEEGELEKIHRKWLNYKHE
CSMQISNSEDSQLSLKSFWGLFLICGITCFMALTVFFWRVFWQYQRLLPESADEERAGEV
SEPSRSGRGSRAPSFKELIKVVDKREAEIKEILKQKSSKKLKSTQSAAGTSQSQHGEIT*
>AT1G05200.2 | ATGLR34 intracellular ligand-gated ion channel
MGFLVMIREVSMAKAIRVVLLCVSVLWVVPKECACRSNFSRNSSSSSSSSLRPLRQRPSS
VNVGALFTYDSFIGRAAKPAVKAAMDDVNADQSVLKGIKLNIIFQDSNCSGFIGTMGALQ
LMENKVVAAIGPQSSGIAHMISYVANELHVPLLSFGATDPTLSSLQFPYFLRTTQNDYFQ
MHAIADFLSYSGWRQVIAIFVDDECGRNGISVLGDVLAKKRSRISYKAAITPGADSSSIR
DLLVSVNLMESRVFVVHVNPDSGLNVFSVAKSLGMMASGYVWIATDWLPTAMDSMEHVDS
DTMDLLQGVVAFRHYTIESSVKRQFMARWKNLRPNDGFNSYAMYAYDSVWLVARALDVFF
RENNNITFSNDPNLHKTNGSTIQLSALSVFNEGEKFMKIILGMNHTGVTGPIQFDSDRNR
VNPAYEVLNLEGTAPRTVGYWSNHSGLSVVHPETLYSRPPNTSTANQRLKGIIYPGEVTK
PPRGWVFPNNGKPLRIGVPNRVSYTDYVSKDKNPPGVRGYCIDVFEAAIELLPYPVPRTY
ILYGDGKRNPSYDNLVNEVVADNFDVAVGDITIVTNRTRYVDFTQPFIESGLVVVAPVKE
AKSSPWSFLKPFTIEMWAVTGGFFLFVGAMVWILEHRFNQEFRGPPRRQLITIFWFSFST
MFFSHRENTVSSLGRFVLIIWLFVVLIINSSYTASLTSILTIRQLTSRIEGIDSLVTSNE
PIGVQDGTFARNYLINELNILPSRIVPLKDEEQYLSALQRGPNAGGVAAIVDELPYIEVL
LTNSNCKFRTVGQEFTRTGWGFAFQRDSPLAVDMSTAILQLSEEGELEKIHRKWLNYKHE
CSMQISNSEDSQLSLKSFWGLFLICGITCFMALTVFFWRVFWQYQRLLPESADEERAGEV
SEPSRSGRGSRAPSFKELIKVVDKREAEIKEILKQKSSKKLKSTQSAAGTSQSQHGEIT*
>AT5G11210.1 | ATGLR25 intracellular ligand-gated ion channel
MASRQGLSSTSETPNKLLLVLPLQKREVVAIIGPGTSMQAPFLINLGNQSKVPIISFSAT
SPLLDSLRSPYFIRATHDDSSQVQAISAIIESFRWREVVPIYVDNEFGEGILPNLVDAFQ
EINVRIRYRSAISLHYSDDQIKKELYKLMTMPTRVFIVHMLPDLGSRLFSIAKEIDMLSK
GYVWIVTNGIADLMSIMGESSLVNMHGVLGVKTYFAKSKELLHLEARWQKRFGGEELNNF
ACWAYDAATALAMSVEEIRHVNMSFNTTKEDTSRDDIGTDLDELGVALSGPKLLDALSTV
SFKGVAGRFQLKNGKLEATTFKIINIEESGERTVGFWKSKVGLVKSLRVDKVSHSSRRLR
PIIWPGDTIFVPKGWEFPTNAKKLRIAVPKKDGFNNFVEVTKDENTNVPTVTGFCIDVFN
TVMSQMPYAVSYEYIPFDTPDGKPRGSYDEMVYNVFLGEFDGAVGDTTILANRSHYVDFA
LPYSETGIVFLVPVKDGKEKGEWVFLKPLTKELWLVTAASFLYIGIMVWIFEYQADEEFR
EQMIIDKISSVFYFSFSTLFFAHRRPSESFFTRVLVVVWCFVLLILTQSYTATLTSMLTV
QELRPTVRHMDDLRKSGVNIGYQTGSFTFERLKQMRFDESRLKTYNSPEEMRELFLHKSS
NGGIDAAFDEVAYIKLFMAKYCSEYSIIEPTFKADGFGFAFPLGSPLVSDISRQILNITE
GDAMKAIENKWFLGEKHCLDSTTSDSPIQLDHHSFEALFLIVFVVSVILLLLMLASRGYQ
ERQHNASPNLPNDQANAAQEEVNEEGNVGDHIVEVDTALAKVSIVKPKL*
>AT2G32730.1 | 26S proteasome regulatory subunit putative
MATPMVSSAGGLLAMLNEPHPVLKLHALSNLNNLVDQFWPEISTSVPIIESLYEDEEFDL
HQRQLAALLVSKVFYYLGELNDSLSYALGAGPLFDVSEDSDYVHTLLAKAIDEYASLRSK
AVESNEMVDIDPRLEAIVERMLGKCISDGKYQQAMGIAIECRRLDKLEEAIIKSDNVQGT
LSYCINVSHSFVNRREYRHEVLSLLVKVYQKLPSPDYLSICQCLMFLDEPQGVASILEKL
LRSENKDDALLALQIAFDLVENEHQAFLLSVRDRLPAPKTRAVEATQAVETTIAPNENPS
GDVQMADETPAQTIVHETDPVDATYAERLTKIKGILSGETSIQLTLQFLYSHNKSDLLIL
KTIKQSVEMRNSVCHSATIYANAIMHAGTTVDTFLRENLDWLSRATNWAKFSATAGLGVI
HRGHLQQGRSLMAPYLPQGGAGGGGSPYSEGGALYALGLIHANHGEGIKQFLRDSLRSTN
VEVIQHGACLGLGLSALGTADEEIYDDVKSVLYTDSAVAGEAAGISMGLLLVGTATEKAS
EMLAYAHETQHEKIIRGLALGIALTVYGREEGADTLIEQMTRDQDPIIRYGGMYALALAY
SGTANNKAIRQLLHFAVSDVSDDVRRTAVLALGFVLYSDPEQTPRIVSLLSESYNPHVRY
GAALAVGISCAGTGLSEAISLLEPLTSDVVDFVRQGALIAMAMVMVQISEASDSRVGVFR
RQLEKIILDKHEDTMSKMGAILASGILDAGGRNVTIRLLSKTKHDKVTAVIGLAVFSQFW
YWYPLIYFISLAFSPTAFIGLNYDLKVPKFEFMSHAKPSLFEYPKPTTVPTANTAVKLPT
AVLSTSVKAKARAKKEAEQKAIAEKTSGPEKPVNESGSGKGKASTEKEGDSMQVDSPAAV
EKKAPEPEPAFEILVNPARVVPAQEKYIKLLDDSRYVPVKLAPSGFVLLKDLREHEPEVL
SLTDAPTSTASPATGTAAAAQGTPASAMAVDDEPQPPQAFEYAS*
>AT3G12280.1 | RBR1 (RETINOBLASTOMA-RELATED 1) transcription factor binding
MEEVQPPVTPPIEPNGKRSEASLLDICEKVLSLDGSTCDEALKLFTETKRILSASMSNIG
SGTREEVERFWFAFILYSVKRLSVRKEADGLSVSGDNEFNLCQILRALKLNIVDFFKELP
QFVVKAGSVLGELYGADWENRLQAKEVQANFVHLSLLSKYYKRGFREFFLTYDANAEKNS
ANSSTYLLDSYRFGWLLFLALRNHAFSRFKDLVTCSNGVVSILAILIIHVPCRFRNFSIQ
DSSRFVKKGDKGVDLVASLCKIYDASEDELRIVIDKANNLVETILKKKPSPASECQTDKL
DNIDPDGLTYFEDLLEETSISTSLITLEKDYYDGKGELDERVFINEEDSLLGSGSLSAGA
VNITGVKRKIDALSSPARTFISPLSPHKSPAAKTNGISGATKLAATPVSTAMTTAKWLRT
VISPLLPKPSPGLEHFLKSCDRDITNDVTRRAHIILEAIFPNSSLGAQCGGGSLQAVDLM
DDIWAEQRRLEACKLYYRVLEAMCKAEAQILHANNLNSLLTNERFHRCMLACSAELVLAT
HKTITMLFPAVLERTGITAFDLSKVIESFIRHEDSLPRELRRHLNSLEERLLESMVWEKG
SSMYNSLIVARPSLALEINQLGLLAEPMPSLDAIAALINFSDGANHASSVQKHETCPGQN
GGIRSPKRLCTDYRSILVERNSFTSPVKDRLLALGNVKSKMLPPPLQSAFASPTRPNPGG
GGETCAETGINIFFTKINKLAAVRINGMVERLQLSQQIRESVYCFFQHVLAQRTSLLFSR
HIDQIILCCFYGVAKISQMSLTFREIIYNYRKQPQCKPLVFRSVYVDALQCRRQGRIGPD
HVDIITFYNEIFIPAVKPLLVELGPVRNDRAVEANNKPEGQCPGSPKVSVFPSVPDMSPK
KVSAVHNVYVSPLRGSKMDALISHSTKSYYACVGESTHAYQSPSKDLSAINNRLNNSSSN
RKRTLNFDAEAGMVSDSMVANSLNLQNQNQNQNGSDASSSGGAAPLKTEPTDS*
>AT3G11870.1 | protein kinase-related
MWLLAISLVGLLVVVVCVFLRFSKDKGLDGIVNEKKRDKNSAPRVSASGEDGTKNEQVEK
KSDPSGGLGEENEKTNSESKVLSVPSDQNINKTLPVMLPSLELRKYDENETPGKVVNRRL
LVSTNEMKYGRNGYEVFQGVYGRRSSVAVKCLDLAHTTEAFIQNEIDNHCLCDDHSNIIR
FHGLEQDQSFAYICLEPWKCSLDDLIKLSVRRTKRDTQAVAPVDDLEKVMKRIKFWKEKG
KPLPLTPMLKLMRDVVCGLAHLHKLKTIHRNLNPQNVLIIVKDMTLTAKISDMSLSKHLG
GKKSSYKHLATCSGSSGWQAPEQLNKDKKKKEDFPADMFNFGCLLHYAVMGTHPFGSPSE
RDTNIKTNNKTNLSLVTNLEAINLIEQLLNYKPDLRPSATQVLLHPLFWDSEKRLFFLRE
ASDRIELDITMWGDLNKTIAPRVLGESKDWASKLGKTFITHIENLAQAQPGQESRQYNRS
YKYWSLRHLLRLIRNILSHHREILDDPKIKEMVGKVPEGLDIFFTARFPNLMMEIYAFIS
MHCKGEEAFEKYFN*
>AT5G24550.1 | BGLU32 (BETA GLUCOSIDASE 32) catalytic/ cation binding / hydrolase hydrolyzing O-glycosyl compounds
MAIKLIALVITICVASWDSAQGRSLRFSTTPLNRYSFPPHFDFGVASSAYQYEGAVEEGG
RSPSIWDNFTHAFPERTNMDNGDVAVDFYHRYKDDIKLIKEMNMDSFRFSLSWSRILPSG
KLSDGVNKEGVQFYKNLIDELIKNGIKPFVTIYHWDIPQALDDEYGSFLSPRIIDDFRNF
ARFCFQEFGDKVSMWTTFNEPYVYSVSGYDAGNKAIGRCSKWVNSLCIAGDSGTEPYLVS
HNLLLAHAAAVEEFRKCDKISQDAKIGIVLSPYWFEPYDIDSESDKEAVERALVFNIGWH
LSPLVFGDYPETIKTTAGNRLPSFTKEQSMMLQNSFDFIGINYYTARFVAHDLHVDLSRP
RFTTDQHLQYKLTNRSGDHISSESDGTKILWSYPEGLRKLLNYIKNKYNNPTIYITENGF
DDYENGSVTREEIIEDTKRIEYHQNHLQQLQKAITEDGCNVKGYFTWSLLDNFEWEHGYA
VRFGLYYVDYKNGLSRHAKNSAKWFKHFLQRSGKPMPLDLFKSVKNWWSAIPMI*
>AT3G51980.1 | binding
MPTIFFFRYVFLLVVISLVGFSIAEKVNSSGGMVWSSVRDEAELVEDSGVVIGEQDQIDG
GFSSLDGMLHWAIGHSDPATLKEAAKDAEKMSLDELQKRQLELKELVEKLKMPSNAKLMQ
IAIDDLNNSSLSLEDRHRALQELLILVEPIDNANDLSKSGGLRVVAGELNHDDTEVRKLA
AWVLGKASQNNPFVQEQVLELGALTTLIKMVNSSSTEEAVKALFAVSALIRNNIAGQDLF
FAAHGYIMLRDVMNNGSLDMKLRRKAVFLVGDLAESQLQNTEKDELPIFKDRLFLKSVVD
LIVVLDLDLQEKALTAIQTLLQLKSIEPQVLKESCGLEEALERMKLQLEESMADEYKRDY
AADVESIRGEVELIFRQKLGLL*
>AT5G62030.1 | diphthamide synthesis DPH2 family protein
MELSDPNNGKTNKPKQPPKRFIKNQIPDSILGDASLNAAISILPSIYHFEVHKCVWRIKT
SNAKRIALQLPEGLLMYALTLSDIFTSFAGASHCFVLGDVTYGACCVDDFSACALGADLL
IHYGHSCLVPIDSTKIPCLYVFVEIQIDVKCLLNTIHLNLASDVKNIILAGTIQFTSAIR
AVKPELEKQGFNVLIPQSKPLSAGEVLGCTAPKVKTVEDCKDQVLVFVADGRFHLEAFMI
ANPKIKAFRYDPYLGKLFLEEYDHKGMRETRMRAIARAREAKTWGIVLGTLGRQGNPKIL
ERLEKKMMEKGIDSTVVLMSELSPTRVALFEDSVDAWVQIACPRLSIDWGEAFLKPLLTT
FEAEIALGFIRGWWENDSSSRVNSSSGCCKEDKETSCACKNENVKDDKKDNDGALDGDYP
MDYYAQEGGEWNSSYLKKSSRPIRRNPLPSSVV*
>AT1G09080.1 | BIP3 ATP binding
MIFIKENTAKMTRNKAIACLVFLTVLDFLMNIGAALMSSLAIEGEEQKLGTVIGIDLGTT
YSCVGVYHNKHVEIIANDQGNRITPSWVAFTDTERLIGEAAKNQAAKNPERTIFDPKRLI
GRKFDDPDVQRDIKFLPYKVVNKDGKPYIQVKVKGEEKLFSPEEISAMILTKMKETAEAF
LGKKIKDAVITVPAYFNDAQRQATKDAGAIAGLNVVRIINEPTGAAIAYGLDKKGGESNI
LVYDLGGGTFDVSILTIDNGVFEVLSTSGDTHLGGEDFDHRVMDYFIKLVKKKYNKDISK
DHKALGKLRRECELAKRSLSNQHQVRVEIESLFDGVDFSEPLTRARFEELNMDLFKKTME
PVKKALKDAGLKKSDIDEIVLVGGSTRIPKVQQMLKDFFDGKEPSKGTNPDEAVAYGAAV
QGGVLSGEGGEETQNILLLDVAPLSLGIETVGGVMTNIIPRNTVIPTKKSQVFTTYQDQQ
TTVTINVYEGERSMTKDNRELGKFDLTGILPAPRGVPQIEVTFEVDANGILQVKAEDKVA
KTSQSITITNDKGRLTEEEIEEMIREAEEFAEEDKIMKEKIDARNKLETYVYNMKSTVAD
KEKLAKKISDEDKEKMEGVLKEALEWLEENVNAEKEDYDEKLKEVELVCDPVIKSVYEKT
EGENEDDDGDDHDEL*
>AT2G32120.1 | HSP70T-2 (HEAT-SHOCK PROTEIN 70T-2) ATP binding
MAEAAYTVASDSENTGEEKSSSSPSLPEIALGIDIGTSQCSIAVWNGSQVHILRNTRNQK
LIKSFVTFKDEVPAGGVSNQLAHEQEMLTGAAIFNMKRLVGRVDTDPVVHASKNLPFLVQ
TLDIGVRPFIAALVNNAWRSTTPEEVLAIFLVELRLMAEAQLKRPVRNVVLTVPVSFSRF
QLTRFERACAMAGLHVLRLMPEPTAIALLYAQQQQMTTHDNMGSGSERLAVIFNMGAGYC
DVAVTATAGGVSQIKALAGSPIGGEDILQNTIRHIAPPNEEASGLLRVAAQDAIHRLTDQ
ENVQIEVDLGNGNKISKVLDRLEFEEVNQKVFEECERLVVQCLRDARVNGGDIDDLIMVG
GCSYIPKVRTIIKNVCKKDEIYKGVNPLEAAVRGAALEGAVTSGIHDPFGSLDLLTIQAT
PLAVGVRANGNKFIPVIPRNTMVPARKDLFFTTVQDNQKEALIIIYEGEGETVEENHLLG
YFKLVGIPPAPKGVPEINVCMDIDASNALRVFAAVLMPGSSSPVVPVIEVRMPTVDDGHG
WCAQALNVKYGATLDLITLQRKM*
>AT2G32120.1 | HSP70T-2 (HEAT-SHOCK PROTEIN 70T-2) ATP binding
MAEAAYTVASDSENTGEEKSSSSPSLPEIALGIDIGTSQCSIAVWNGSQVHILRNTRNQK
LIKSFVTFKDEVPAGGVSNQLAHEQEMLTGAAIFNMKRLVGRVDTDPVVHASKNLPFLVQ
TLDIGVRPFIAALVNNAWRSTTPEEVLAIFLVELRLMAEAQLKRPVRNVVLTVPVSFSRF
QLTRFERACAMAGLHVLRLMPEPTAIALLYAQQQQMTTHDNMGSGSERLAVIFNMGAGYC
DVAVTATAGGVSQIKALAGSPIGGEDILQNTIRHIAPPNEEASGLLRVAAQDAIHRLTDQ
ENVQIEVDLGNGNKISKVLDRLEFEEVNQKVFEECERLVVQCLRDARVNGGDIDDLIMVG
GCSYIPKVRTIIKNVCKKDEIYKGVNPLEAAVRGAALEGAVTSGIHDPFGSLDLLTIQAT
PLAVGVRANGNKFIPVIPRNTMVPARKDLFFTTVQDNQKEALIIIYEGEGETVEENHLLG
YFKLVGIPPAPKGVPEINVCMDIDASNALRVFAAVLMPGSSSPVVPVIEVRMPTVDDGHG
WCAQALNVKYGATLDLITLQRKM*
>AT2G32120.2 | HSP70T-2 (HEAT-SHOCK PROTEIN 70T-2) ATP binding
MAEAAYTVASDSENTGEEKSSSSPSLPEIALGIDIGTSQCSIAVWNGSQVHILRNTRNQK
LIKSFVTFKDEVPAGGVSNQLAHEQEMLTGAAIFNMKRLVGRVDTDPVVHASKNLPFLVQ
TLDIGVRPFIAALVNNAWRSTTPEEVLAIFLVELRLMAEAQLKRPVRNVVLTVPVSFSRF
QLTRFERACAMAGLHVLRLMPEPTAIALLYAQQQQMTTHDNMGSGSERLAVIFNMGAGYC
DVAVTATAGGVSQIKALAGSPIGGEDILQNTIRHIAPPNEEASGLLRVAAQDAIHRLTDQ
ENVQIEVDLGNGNKISKVLDRLEFEEVNQKVFEECERLVVQCLRDARVNGGDIDDLIMVG
GCSYIPKVRTIIKNVCKKDEIYKGVNPLEAAVRGAALEGAVTSGIHDPFGSLDLLTIQAT
PLAVGVRANGNKFIPVIPRNTMVPARKDLFFTTVQDNQKEALIIIYEGEGETVEENHLLG
YFKLVGIPPAPKGVPEINVCMDIDASNALRVFAAVLMPGSSSPVVPVIEVRMPTVDDGHG
WCAQALNVKYGATLDLITLQRKM*
>AT2G32120.2 | HSP70T-2 (HEAT-SHOCK PROTEIN 70T-2) ATP binding
MAEAAYTVASDSENTGEEKSSSSPSLPEIALGIDIGTSQCSIAVWNGSQVHILRNTRNQK
LIKSFVTFKDEVPAGGVSNQLAHEQEMLTGAAIFNMKRLVGRVDTDPVVHASKNLPFLVQ
TLDIGVRPFIAALVNNAWRSTTPEEVLAIFLVELRLMAEAQLKRPVRNVVLTVPVSFSRF
QLTRFERACAMAGLHVLRLMPEPTAIALLYAQQQQMTTHDNMGSGSERLAVIFNMGAGYC
DVAVTATAGGVSQIKALAGSPIGGEDILQNTIRHIAPPNEEASGLLRVAAQDAIHRLTDQ
ENVQIEVDLGNGNKISKVLDRLEFEEVNQKVFEECERLVVQCLRDARVNGGDIDDLIMVG
GCSYIPKVRTIIKNVCKKDEIYKGVNPLEAAVRGAALEGAVTSGIHDPFGSLDLLTIQAT
PLAVGVRANGNKFIPVIPRNTMVPARKDLFFTTVQDNQKEALIIIYEGEGETVEENHLLG
YFKLVGIPPAPKGVPEINVCMDIDASNALRVFAAVLMPGSSSPVVPVIEVRMPTVDDGHG
WCAQALNVKYGATLDLITLQRKM*
>AT2G02750.1 | pentatricopeptide (PPR) repeat-containing protein
MINLTRQRYRVSNLVTGGTSLDVILSHSPNKFTFPPLLKSCAKLGDVVQGRILHAQVVKT
GFFVDVFTATALVSMYMKVKQVTDALKVLDEMPERGIASVNAAVSGLLENGFCRDAFRMF
GDARVSGSGMNSVTVASVLGGCGDIEGGMQLHCLAMKSGFEMEVYVGTSLVSMYSRCGEW
VLAARMFEKVPHKSVVTYNAFISGLMENGVMNLVPSVFNLMRKFSSEEPNDVTFVNAITA
CASLLNLQYGRQLHGLVMKKEFQFETMVGTALIDMYSKCRCWKSAYIVFTELKDTRNLIS
WNSVISGMMINGQHETAVELFEKLDSEGLKPDSATWNSLISGFSQLGKVIEAFKFFERML
SVVMVPSLKCLTSLLSACSDIWTLKNGKEIHGHVIKAAAERDIFVLTSLIDMYMKCGLSS
WARRIFDRFEPKPKDPVFWNVMISGYGKHGECESAIEIFELLREEKVEPSLATFTAVLSA
CSHCGNVEKGSQIFRLMQEEYGYKPSTEHIGCMIDLLGRSGRLREAKEVIDQMSEPSSSV
YSSLLGSCRQHLDPVLGEEAAMKLAELEPENPAPFVILSSIYAALERWEDVESIRQVIDQ
KQLVKLPGLSLSG*
>AT1G71770.1 | PAB5 (POLY(A)-BINDING PROTEIN 5) RNA binding / poly(A) binding / translation initiation factor
MVDQVIPNQPTVAAAAPPPFPAVSQVAAVAAAAAAAEALQTHPNSSLYVGDLDPSVNESH
LLDLFNQVAPVHNLRVCRDLTHRSLGYAYVNFANPEDASRAMESLNYAPIRDRPIRIMLS
NRDPSTRLSGKGNVFIKNLDASIDNKALYETFSSFGTILSCKVAMDVVGRSKGYGFVQFE
KEETAQAAIDKLNGMLLNDKQVFVGHFVRRQDRARSESGAVPSFTNVYVKNLPKEITDDE
LKKTFGKYGDISSAVVMKDQSGNSRSFGFVNFVSPEAAAVAVEKMNGISLGEDVLYVGRA
QKKSDREEELRRKFEQERISRFEKLQGSNLYLKNLDDSVNDEKLKEMFSEYGNVTSCKVM
MNSQGLSRGFGFVAYSNPEEALLAMKEMNGKMIGRKPLYVALAQRKEERQAHLQSLFTQI
RSPGTMSPVPSPMSGFHHHPPGGPMSGPHHPMFIGHNGQGLVPSQPMGYGYQVQFMPGMR
PGAGPPNFMMPFPLQRQTQPGPRVGFRRGANNMQQQFQQQQMLQQNASRFMGGAGNRRNG
MEASAPQGIIPLPLNASANSHNAPQRSHKPTPLTISKLASDLALASPDKHPRMLGDHLYP
LVEQQEPANAAKVTGMLLEMDQAEILHLLESPEALKAKVSEALDVLRRSADPAAVSSVDD
QFALSSSE*